Glenmark Pharma Said It Has Received Final Approval From The US Health Regulator

Glenmark Pharma said it has received final approval from the US health regulator for Colesevelam Hydrochloride tablets, 625 mg, the generic version of Daiichi Sankyo's Welchol tablets, 625 mg.

"Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration for Colesevelam Hydrochloride tablets, 625 mg," the company said in a BSE filing today.

For more information Call us ✆ +91 9111-179961 or Visit Dollar Advisory